Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Juan Pablo
Incremental yield of genetic retesting in hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the most frequent inherited cardiovascular disease.
Genetic counselling implementation in dilated cardiomyopathy: A clinical consensus statement of the Heart Failure Association of the ESC, the ESC Working Group on Myocardial and Pericardial Diseases, and the ESC Council on Cardiovascular Genomics Open Acc
Dilated cardiomyopathy (DCM) is a heterogeneous disease that can be caused by both environmental and genetic triggers and combinations thereof. Recent data have shown that an apparently acquired aetiology for DCM does not exclude the presence of an underlying disease-associated genetic variant, emphasizing the importance of considering genetic testing in all patients with DCM.
CRISPR activation to repair electrocardiogram abnormalities caused by a FLNC truncating variant in mice
Truncating variants in the Filamin C (FLNC) gene (FLNCtv) are one of the most frequent causes of genetic dilated cardiomyopathy (DCM) and non-dilated left ventricular (LV) cardiomyopathy.1,2 In both cardiomyopathies, arrhythmic manifestations and sudden cardiac death are strong components of the disease and rarely improve after its onset.1 There is no specific therapy for FLNCtv-induced cardiomyopathy and electrical manifestations of the disease.
Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure
See the editorial comment for this article ‘Arrhythmic risk and advanced heart failure in dilated cardiomyopathy: a deadly tango’, by J.-B. le Polain de Waroux et al., https://doi.org/10.1093/eurheartj/ehaf475.
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags
The European Society of Cardiology guidelines recommend a systematic search for diagnostic clues or ‘red flags’ (RFs) in patients with hypertrophic cardiomyopathy (HCM) to better tailor disease management. To date, the prevalence and clinical significance of RF associated with HCM phenotypes in different clinical settings are unknown. The study cohort comprised 818 patients with a clinical diagnosis of HCM [479 (62%) males, mean age 49 ± 21 years] referred to four European centres.
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry
Cardiomyopathies are a heterogeneous group of diseases characterized by structural and functional abnormalities of the myocardium that are unexplained by abnormal loading conditions.
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry
A total of 633 individuals aged ≤18 years with hypertrophic [HCM; n = 388 (61.3%)], dilated [DCM; n = 206 (32.5%)], restrictive [RCM; n = 28 (4.4%)], and arrhythmogenic right ventricular cardiomyopathy [ARVC; n = 11 (1.7%)] were enrolled by 23 referral centres in 14 countries.
The 2023 ESC guidelines for the management of cardiomyopathies: the 10 commandments
The 2023 European Society of Cardiology Guidelines for the Management of Cardiomyopathies1 represent the first international clinical practice guideline covering the full range of cardiomyopathies throughout the life course. As this is a new guideline (except for hypertrophic cardiomyopathy, for which a focused update has been provided), most of the 158 recommendations are new.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Juan
Contact Juan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack